NVNO Financial Statements

Balance sheet, income statement, cash flow, and dividends for Envveno Medical Corp (NVNO).


$52.96M Market Cap.

As of 03/01/2025 5:00 PM ET (MRY) • Disclaimer

NVNO Market Cap. (MRY)


NVNO Shares Outstanding (MRY)


NVNO Assets (MRY)


Total Assets

$44.95M

Total Liabilities

$2.79M

Total Investments

$41.40M

NVNO Income (MRY)


Revenue

$0

Net Income

-$21.82M

Operating Expense

$23.83M

NVNO Cash Flow (MRY)


CF Operations

-$16.84M

CF Investing

$1.33M

CF Financing

$13.64M

NVNO Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

NVNO Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$44,954,000 (-7.57%)

$48,635,000 (16.74%)

$41,661,000 (-27.80%)

$57,699,000 (447.54%)

Assets Current

$43,734,000 (-6.80%)

$46,923,000 (18.99%)

$39,436,000 (-28.35%)

$55,040,000 (475.19%)

Assets Non-Current

$1,220,000 (-28.74%)

$1,712,000 (-23.06%)

$2,225,000 (-16.32%)

$2,659,000 (174.47%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$42,159,000 (-8.75%)

$46,200,000 (19.29%)

$38,729,000 (-28.81%)

$54,404,000 (666.48%)

Property Plant & Equipment Net

$1,189,000 (-29.27%)

$1,681,000 (-23.38%)

$2,194,000 (-15.78%)

$2,605,000 (177.44%)

Cash & Equivalents

$1,754,000 (-51.55%)

$3,620,000 (-20.53%)

$4,555,000 (-91.68%)

$54,728,000 (486.29%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$41,399,000 (-3.26%)

$42,792,000 (24.07%)

$34,489,000 (0%)

$0 (0%)

Investments Current

$41,399,000 (-3.26%)

$42,792,000 (24.07%)

$34,489,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$1,731,000 (67.57%)

$1,033,000 (-15.05%)

$1,216,000 (117.14%)

$560,000 (-59.72%)

Accumulated Retained Earnings (Deficit)

-$151,855,000 (-16.78%)

-$130,036,000 (-22.08%)

-$106,520,000 (-30.14%)

-$81,851,000 (-25.30%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$1,064,000 (-24.11%)

$1,402,000 (-18.30%)

$1,716,000 (-14.46%)

$2,006,000 (127.79%)

Debt Current

$364,000 (7.69%)

$338,000 (7.64%)

$314,000 (7.90%)

$291,000 (-53.58%)

Debt Non-Current

$700,000 (-34.21%)

$1,064,000 (-24.11%)

$1,402,000 (-18.25%)

$1,715,000 (575.87%)

Total Liabilities

$2,795,000 (14.78%)

$2,435,000 (-16.95%)

$2,932,000 (-11.02%)

$3,295,000 (-4.21%)

Liabilities Current

$2,095,000 (52.81%)

$1,371,000 (-10.39%)

$1,530,000 (-3.16%)

$1,580,000 (-50.41%)

Liabilities Non-Current

$700,000 (-34.21%)

$1,064,000 (-24.11%)

$1,402,000 (-18.25%)

$1,715,000 (575.87%)

NVNO Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$11,577,000 (-0.67%)

$11,655,000 (-22.39%)

$15,018,000 (34.51%)

$11,165,000 (128.66%)

Research & Development Expense

$12,249,000 (-9.82%)

$13,583,000 (37.01%)

$9,914,000 (73.08%)

$5,728,000 (34.71%)

Operating Expenses

$23,826,000 (-5.59%)

$25,238,000 (1.23%)

$24,932,000 (47.59%)

$16,893,000 (84.92%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$21,819,000 (7.22%)

-$23,516,000 (4.67%)

-$24,669,000 (-49.26%)

-$16,528,000 (-80.92%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$21,819,000 (7.22%)

-$23,516,000 (4.67%)

-$24,669,000 (-49.26%)

-$16,528,000 (-80.92%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$21,819,000 (7.22%)

-$23,516,000 (4.67%)

-$24,669,000 (-49.26%)

-$16,528,000 (-69.64%)

Weighted Average Shares

$17,142,000 (39.35%)

$12,301,000 (9.54%)

$11,230,000 (29.38%)

$8,680,000 (572.10%)

Weighted Average Shares Diluted

$17,142,000 (39.35%)

$12,301,000 (9.54%)

$11,230,000 (29.38%)

$8,680,000 (572.10%)

Earning Before Interest & Taxes (EBIT)

-$21,819,000 (7.22%)

-$23,516,000 (4.67%)

-$24,669,000 (-49.26%)

-$16,528,000 (-80.85%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$23,826,000 (5.59%)

-$25,238,000 (-1.23%)

-$24,932,000 (-47.59%)

-$16,893,000 (-84.92%)

NVNO Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$1,335,000 (116.97%)

-$7,868,000 (77.23%)

-$34,554,000 (-9289.67%)

-$368,000 (-104.11%)

Net Cash Flow from Financing

$13,637,000 (-47.12%)

$25,791,000 (0%)

$0 (0%)

$57,607,000 (282.14%)

Net Cash Flow from Operations

-$16,838,000 (10.71%)

-$18,858,000 (-20.74%)

-$15,619,000 (-31.83%)

-$11,848,000 (-54.33%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$1,866,000 (-99.57%)

-$935,000 (98.14%)

-$50,173,000 (-210.54%)

$45,391,000 (528.92%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$1,372,000 (117.51%)

-$7,835,000 (77.25%)

-$34,439,000 (0%)

$0 (0%)

Capital Expenditure

-$37,000 (-12.12%)

-$33,000 (71.30%)

-$115,000 (68.75%)

-$368,000 (-104.11%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$13,637,000 (-47.12%)

$25,791,000 (0%)

$0 (0%)

$57,607,000 (329.77%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$4,141,000 (-20.30%)

$5,196,000 (-42.23%)

$8,994,000 (49.92%)

$5,999,000 (580.77%)

Depreciation Amortization & Accretion

$528,000 (-3.30%)

$546,000 (4.00%)

$525,000 (15.89%)

$453,000 (17.98%)

NVNO Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-51.20% (27.07%)

-70.20% (-27.64%)

-55.00% (-63.20%)

-33.70% (89.41%)

Return on Average Assets (ROAA)

-48.20% (25.50%)

-64.70% (-25.39%)

-51.60% (-59.26%)

-32.40% (79.98%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-56.70% (22.01%)

-72.70% (8.09%)

-79.10% (94.41%)

-1413.90% (-155.81%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.38 (11.63%)

-2.69 (-16.09%)

-2.32 (33.16%)

-3.47 (-202.35%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

1.26 (-15.25%)

1.48 (18.85%)

1.25 (8.72%)

1.15 (-52.72%)

Debt to Equity Ratio (D/E)

0.07 (24.53%)

0.05 (-30.26%)

0.08 (24.59%)

0.06 (-87.42%)

Earnings Per Share (EPS)

-1.27 (33.51%)

-1.91 (13.18%)

-2.2 (-15.79%)

-1.9 (74.80%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.98 (35.94%)

-1.54 (-9.64%)

-1.4 (0.43%)

-1.41 (76.87%)

Book Value Per Share (BVPS)

2.46 (-34.53%)

3.76 (8.90%)

3.45 (-44.97%)

6.27 (14.05%)

Tangible Assets Book Value Per Share (TABVPS)

2.62 (-33.69%)

3.95 (6.58%)

3.71 (-44.19%)

6.65 (-18.54%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (33.33%)

-3 (-50.00%)

-2 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.7 (39.91%)

-2.83 (-44.71%)

-1.96 (-549.50%)

-0.3 (79.00%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

20.88 (-39.01%)

34.23 (32.78%)

25.77 (-26.01%)

34.84 (1060.01%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$16,875,000 (10.67%)

-$18,891,000 (-20.06%)

-$15,734,000 (-28.80%)

-$12,216,000 (-55.47%)

Enterprise Value (EV)

$36,191,720 (-44.31%)

$64,982,380 (37.67%)

$47,200,853 (876.91%)

$4,831,630 (-61.49%)

Earnings Before Tax (EBT)

-$21,819,000 (7.22%)

-$23,516,000 (4.67%)

-$24,669,000 (-49.26%)

-$16,528,000 (-80.92%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$21,291,000 (7.31%)

-$22,970,000 (4.86%)

-$24,144,000 (-50.20%)

-$16,075,000 (-83.60%)

Invested Capital

$42,169,000 (-6.39%)

$45,046,000 (20.79%)

$37,292,000 (997.79%)

$3,397,000 (408.16%)

Working Capital

$41,639,000 (-8.59%)

$45,552,000 (20.17%)

$37,906,000 (-29.09%)

$53,460,000 (737.56%)

Tangible Asset Value

$44,954,000 (-7.57%)

$48,635,000 (16.74%)

$41,661,000 (-27.80%)

$57,699,000 (447.54%)

Market Capitalization

$52,958,720 (-22.63%)

$68,449,380 (41.70%)

$48,306,853 (-22.58%)

$62,396,255 (262.30%)

Average Equity

$42,579,000 (27.05%)

$33,514,000 (-25.22%)

$44,818,750 (-8.69%)

$49,085,976 (1503.12%)

Average Assets

$45,292,000 (24.58%)

$36,357,000 (-23.97%)

$47,818,250 (-6.37%)

$51,069,504 (748.20%)

Invested Capital Average

$38,515,250 (19.14%)

$32,329,000 (3.62%)

$31,198,750 (2568.96%)

$1,168,950 (424.05%)

Shares

17,536,000 (31.68%)

13,317,000 (40.59%)

9,471,932 (0.04%)

9,468,324 (375.55%)